288 related articles for article (PubMed ID: 38492089)
1. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment.
Zhang X; Wang H; Zhang Y; Wang X
Clin Exp Med; 2024 Mar; 24(1):54. PubMed ID: 38492089
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in chronic lymphocytic leukemia.
Raval A; Byrd JC; Plass C
Semin Oncol; 2006 Apr; 33(2):157-66. PubMed ID: 16616062
[TBL] [Abstract][Full Text] [Related]
6. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
[TBL] [Abstract][Full Text] [Related]
7. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL.
Pastore A; Gaiti F; Lu SX; Brand RM; Kulm S; Chaligne R; Gu H; Huang KY; Stamenova EK; Béguelin W; Jiang Y; Schulman RC; Kim KT; Alonso A; Allan JN; Furman RR; Gnirke A; Wu CJ; Melnick AM; Meissner A; Bernstein BE; Abdel-Wahab O; Landau DA
Nat Commun; 2019 Apr; 10(1):1874. PubMed ID: 31015400
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
9. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
Kulis M; Martin-Subero JI
Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
Chen SS; Raval A; Johnson AJ; Hertlein E; Liu TH; Jin VX; Sherman MH; Liu SJ; Dawson DW; Williams KE; Lanasa M; Liyanarachchi S; Lin TS; Marcucci G; Pekarsky Y; Davuluri R; Croce CM; Guttridge DC; Teitell MA; Byrd JC; Plass C
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13433-8. PubMed ID: 19666576
[TBL] [Abstract][Full Text] [Related]
11. Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age.
Nannini DR; Cortese R; Egwom P; Palaniyandi S; Hildebrandt GC
Clin Epigenetics; 2023 May; 15(1):81. PubMed ID: 37165442
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
13. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
14. Genetics and molecular biology of chronic lymphocytic leukemia.
Carney DA; Wierda WG
Curr Treat Options Oncol; 2005 May; 6(3):215-25. PubMed ID: 15869733
[TBL] [Abstract][Full Text] [Related]
15. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
Giacopelli B; Zhao Q; Ruppert AS; Agyeman A; Weigel C; Wu YZ; Gerber MM; Rabe KG; Larson MC; Lu J; Blachly JS; Rogers KA; Wierda WG; Brown JR; Rai KR; Keating M; Rassenti LZ; Kipps TJ; Zenz T; Shanafelt TD; Kay NE; Abruzzo LV; Coombes KR; Woyach JA; Byrd JC; Oakes CC
Blood; 2019 Aug; 134(8):688-698. PubMed ID: 31292113
[TBL] [Abstract][Full Text] [Related]
16. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
20. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]